Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
411. |
ECCT/15/06/02 | ZINC in Sickle cell study The effects of Zinc supplementation in children with sickle cell disease in Western Kenya: a pilot study. |
Principal Investigator(s) 1. Lucas Otieno Tina Site(s) in Kenya Health Facilities in Western Kenya |
View |
412. |
ECCT/15/06/01 | Pyronaridine-artesunate and artemether-lumefantrine for the treatment of paediatric uncomplicated falciparum malaria in Western Kenya |
Principal Investigator(s) 1. Patrick Sawa Site(s) in Kenya St. Judes Clinic, ICIPE |
View |
413. |
ECCT/15/06/04 | A5316 A5316 Evaluating Pharmacokinetic Interactions with Vaginal Ring Contraceptives and Antiretroviral Therapy |
Principal Investigator(s) 1. Dr. Esther Mumbi Makanga Makanga 2. Dr. Victor Akelo Akelo 3. Dr.Victor O. Mudhune Mudhune 4. Dr. Kevin P. Cain Cain Site(s) in Kenya KEMRI- CDC |
View |
414. |
ECCT/15/05/01 | Janssen Ebola vaccine study A Randomized, Observer-blind, Placebo-controlled, Phase 2 Study to Evaluate the Safety, Tolerability and Immunogenicity of Different Prime-boost Regimens of the Candidate Prophylactic Vaccines for Ebola Ad26.ZEBOV and MVA-BN-Filo in Healthy Adults, Including Elderly Subjects, HIV-infected Subjects, and Healthy Children in Two Age Strata in Africa |
Principal Investigator(s) 1. Prof Omu Aggrey Anzala Site(s) in Kenya KAVI –Institute of Clinical Research |
View |
415. |
ECCT/15/04/02 | Plasma concentration profiles after oral administration of oleylphosphocholine tablet formulation: safety, tolerability and pharmacokinetics of 100 mg single dose in healthy male volunteers. |
Principal Investigator(s) 1. Ravasco Rashid Juma Site(s) in Kenya KEMRI |
View |